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Abstract The inhibitory effect of actin on protein phosphoryla- 
tion by three distinct protein kinases (CK-II, A-kinase and 
MAP-kinase) was examined in vitro. It was found that: (i) actin 
inhibits the activities of ~-monomeric CK-II (CK-II~) as well as 
oligomeric CK-II (~[~)  in a dose-dependent manner, but has no 
effect on the activities of the two other kinases; and (ii) actin- 
induced inhibition of CK-II activity is due to the binding of actin 
to the a-subunit of CK-II and is non-competitive with its 
phosphate acceptors. In addition, it is demonstrated that actin 
binds directly to CK-II: both actin and CK-II are coprecipitated 
by anti-serum against Drosophila CK-II[~ or by specific IgG 
against Ascaris suum muscle actin. The results presented here 
suggest hat actin can suppress CK-II-mediated signal transduc- 
tion. 
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1. Introduction 
Casein kinase II (CK-II) is a highly conserved, cAMP-, 
cGMP- and Ca2+-independent serine/threonine protein ki- 
nase, which has been characterized in numerous mammalian 
and plant cells [1,2]. CK-II  is composed of three distinct sub- 
units [a, ct' (35-42 kDa) and [3 (24-28 kDa)], which exist in 
solution as a tetramer of ct21~2, otc~'~2 or ct'2132 (approx. 130- 
150 kDa) [3]. The c~- and a'-subunits, which are the products 
of different genes, contain the catalytic site of CK-II, whereas 
the [3-subunit, which undergoes autophosphorylation, is re- 
sponsible for regulation of CK-II  activity by its direct inter- 
action with CK-II  activators, such as basic polypeptides [1,4]. 
Recent reports show that CK-II  plays important roles in the 
initiation of DNA replication and transcription: it specifically 
modifies DNA-binding proteins (DNA topoisomerases [5]and 
SV-40 large T antigen [6]), transcriptional factors (Spl [7], 
serum response factor (SRF) [8] and Ap-1 [9]), some oncogene 
products (erbAa [10], Myb [11] and Myc [12]) and suppressor 
gene product, p53 [13]. 
Recently, we reported that (i) DNA-binding sperm proteins 
with oligo-Arg clusters are responsible for activation of egg 
CK-II  during fertilization in sea urchin eggs; and (ii) the 
protein-protein i teraction between oligo-Arg and a cluster 
(DLEPEDELED) of acidic amino acid residues at positions 
55-64 of CK-II[3 is involved in CK-II  activation [14]. In our 
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preliminary experiments concerning the purification and char- 
acterization of specific suppressive factors for CK-II  in mam- 
malian cells, a 44 kDa protein (p44), which inhibited CK-II  
activity in vitro, was purified from the cell extracts from brain 
and liver of mouse by means of protamine-affinity column 
chromatography. Determination of the N-terminal amino 
acid sequence of p44 identified the CK-II  inhibitor as actin. 
Therefore, the present study was undertaken to characterize 
actin (as a potent inhibitor for CK-II  activity. Here, we de- 
scribe the biochemical characterization f an active actin from 
rabbit muscle as a CK-II  inhibitor in vitro. This is the first 
report of such a novel in vitro inhibitory effect of actin. 
2. Materials and methods 
2.1. Chemicals 
[y-32p]ATP (3000 Ci/mmol), [y-32p]GTP (5000 Ci/mmol) and 12~I 
(100 mCi/ml) were obtained from Amersham (Arlington Heights, 
IL, USA); DTT, PMSF, poly-Arg, heparin, dephosphorylated m-case- 
in (bovine milk) and myelin basic protein from Sigma Chemical Co. 
(St. Louis, MO, USA); histone H2B (calf thymus) from Boehringer- 
Mannheim Biochemicals (Germany); and murine MAP-kinase (Erk 2) 
from New England Biolabs Inc. (MA, USA). 
2.2. Preparation of actin from rabbit skeletal muscle 
Actins in acetone powder prepared from rabbit skeletal muscle were 
purified according to a modification of the method of Pardee and 
Spudich [15]. Briefly, the acetone powder (about 10 g) was suspended 
in 200 ml of 2 mM Tris-HC1 (pH 8.0) containing 0.2 mM CaC12, 0.5 
mM DTT and 0.2 mM ATP. After centrifugation (100 000 × g for 40 
min at 4°C), actin in the supernatant was fully polymerized in 50 mM 
KC1 containing 2 mM MgC12 and 1 mM ATP. The polymerized actin 
was treated with 0.6 M KCI and dialyzed for 3 days against 2 mM 
Tris-HC1 (pH 8.0) containing 0.2 mM CaCI~, 0.5 mM DTT and 0.2 
mM ATP to depolymerize it. Since SDS-PAGE detected actin as a 
single polypeptide (approx. 44 kDa) in the dialysate, this preparation 
was used as a source of purified actin. 
2.3. Purification of CK-H and A-kinase 
Oligomeric CK-II (ct2132) from mouse brain [16], c~-monomeric CK- 
II from plant cells [17] and A-kinase from mouse spleen cells [18] were 
separately purified, as reported previously. 
2.4. Assay for the activities of protein kinases 
CK-II activity was measured in the standard reaction mixture (50 
/.tl), which comprised 40 mM Tris-HC1 (pH 7.6), 2 mM DTT, 3 mM 
Mn 2+, 3 I.tg of m-casein (phosphate acceptor), 40 IxM [y-32p]ATP (500 
cpm/pmol) and the indicated amounts of purified CK-II. After incu- 
bation for the indicated periods at 30°C in the presence or absence of 
poly-Arg (3 p.g, CK-II activator), 32p-labeled casein on the filter was 
determined with a liquid scintillation spectrometer, as reported pre- 
viously [15]. A-kinase activity was measured in a reaction mixture 
comprising 40 mM Tris-HCl (pH 7.0), 4 mM DTT, 10 mM Mg 2+, 
2 IxM cAMP, 3 Ixg of histone H2B (phosphate acceptor), 40 /aM [7- 
32p]ATP (500 cpm/pmol) and the indicated amounts of purified A- 
kinase. MAP-kinase activity was assayed in a reaction mixture com- 
prising 50 mM Tris-HCl (pH 7.5), 1 mM DTT, 10 mM Mg 2+, 3 p~g of 
myelin basic protein (phosphate acceptor), 40 ~tM [?-32p]ATP (500 
cpm/pmol) and the indicated amounts of MAP-kinase. After incuba- 
tion (20 min at 30°C), 32p-labeled substrates [histone H2B or myelin 
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Fig. 1. (A) Effect of actin on the activities of three distinct protein kinases in vitro. The protein kinase activities were assayed separately under 
standard assay conditions in the presence of the indicated concentrations of actin. After incubation (20 min at 30°C) and SDS-PAGE, z2P-la- 
beled protein substrates were detected by autoradiography. Phosphorylations were a-casein (3 txg) by CK-II (approx. 0.1 p-g, lanes 1-4), histone 
H2B (3 p-g) by A-kinase (approx. 0.1 p.g, lanes 5-8) and MBP (3 p.g) by MAP-kinase (approx. 0.1 p.g, lanes 9-12). Lanes 1,5,9, absence of ac- 
tin; lanes 2,6,10, 0.4 p-g of actin; lanes 3,7,11, 1.2 p-g of actin; and lanes 4,8,12, 4 ~g of actin. (B) Interaction of actin filaments and three dis- 
tinct protein kinases. Actin (5 ~g) was incubated at 4°C for 1 h in a buffer solution consisting of 40 mM Tris-HCl (pH 7.6) 2 mM Mg 2+ and 
0.1 M KC1 in the presence of one of three protein kinases (a, CK-II; b, A-kinase; and c, MAP-kinase). After centrifugation at 100000×g for 
1 h at 2°C, the catalytic subunits of these three kinases in the supernatants ( ) and precipitates (p) obtained were detected by the active gel 
method [20]. 
basic protein (MBP)] were determined by SDS-PAGE followed by 
autoradiography. 
2.5. SDS-PAGE and autoradiography 
SDS-PAGE followed by autoradiography to detect 32p-labeled 
polypeptides was performed according to method originally described 
by Laemmli [19], after protein phosphorylation by the indicated pro- 
tein kinases, as reported in [14]. 
2.6. Detection of the catalytic subunits of protein kinases 
The catalytic subunits of protein kinases on the electrophoresis gel 
were detected by a modification of a method described originally by 
Kameshita nd Fujisawa [20]. The gel was washed twice with buffer 
[50 mM Tris-HC1 (pH 8.0) and 5 mM 2-mercaptoethanol (2-ME)] 
containing 20% 2-propanol, and then rinsed in the same buffer for 
1 h at room temperature. The subunits of protein kinases were rena- 
tured with 6 M guanidine-HCl in the same buffer for 1 h at room 
temperature, and then renatured with the same buffer containing 
0.04% Tween 40 for 18 h at 4°C. After renaturation, protein phos- 
phorylation was performed by incubation of the gel in 2.5 ml of a 
buffer [40 mM HEPES-NaOH (pH 8.0), 2 mM 2-ME and 3 mM 
Mn 2+] containing 20 p-M [7-32p]ATP (2000 cpm/pmol) for 1 h at 
room temperature. After washing the gel extensively with 5% (w/v) 
trichloroacetic acid containing 1% sodium pyrophosphate, the 32p. 
labeled catalytic subunits of protein kinases on the gel were detected 
by autoradiography. 
3. Results 
3.1. Selective inhibitory effect of  actin on CK-H activity in vitro 
To characterize the inhibitory effect of actin from rabbit 
skeletal muscle on the activities of  three distinct serine/threo- 
nine protein kinases (CK-II, A-kinase and MAP-kinase), they 
were separately assayed in the presence of actin at the indi- 
cated doses in vitro. It was found that actin inhibited CK-I I  
activity in a dose-dependent manner, but did not affect the 
activities of the two other kinases (Fig. 1A). 
To confirm the direct interaction between actin and these 
three kinases, it was incubated separately with each kinase 
under conditions conducive to actin polymerization. After sep- 
aration of polymerized actin by centrifugation, the catalytic 
subunits of the three kinases in the supernatant and the pre- 
cipitate fractions were detected by the active gel method [20]. 
As shown in Fig. 1 B, CK-I I  activity was detected in the pre- 
cipitate fraction of the polymerized actin, whereas the catalyt- 
ic subunits of  the two other kinases (A-kinase and MAP- 
kinase) were detected only in the supernatants. These results 
suggest hat, among the three kinases tested, only CK-I I  ex- 
hibits complex formation on incubation with actin in vitro. 
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Fig. 2. (A) Coimmunoprecipitation of actin and oligomeric CK-II 
with anti-CK-II~ antibody in vitro. 125I-labeled actin and oligomeric 
CK-II (approx. 0.1 ~tg) were incubated for 12 h at room tempera- 
ture with either rabbit anti-serum against Drosophila CK-II~ anti- 
body (lane 3) or normal rabbit serum (lane 4). After incubation for 
a further 2 h in the presence of protein A-Sepharose, the resulting 
immunoprecipitates were washed four times with buffer [10 mM 
Tris-HC1 (pH 7.6), 0.15 M NaC1 and 1% NP-40], and then sub- 
jected to SDS-PAGE followed by autoradiography. Lane l, 125I-la- 
beled actin as a control; lane 2, 125I-labeled actin incubated for 12 
h at room temperature with anti-CK-III3 antibody in the absence of 
oligomeric CK-II. (B) Direct binding of oligomeric CK-II to actin 
in vitro. Purified actin (approx. 2 lag) and oligomeric CK-II (ap- 
prox. 0.1 lag) were incubated for 1 h at room temperature, and then 
incubated for 12 h with either rabbit anti-IgG against Ascaris suum 
muscle actin [21] or normal rabbit serum, After incubation for a 
further 2 h in the presence of protein A-Sepharose, the resulting im- 
munocomplexes were washed four times with washing buffer [10 
mM Tris-HC1 (pH 7.6), 0.15 M NaC1 and 1%o NP-40], and subjected 
to the active gel phosphorylation assay [20] to detect he a-catalytic 
subunit of CK-II (CK-II~). Actin and CK-II were incubated with 
anti-IgG against Ascaris suum muscle actin (lane 1) or normal rab- 
bit serum (lane 2) in the presence of protein A-Sepharose. Lane 3, 
mouse CK-II (t:t2132) as a control. 
3.2. Direct binding o f  actin to CK-H 
The above experimental result that CK-II  was coprecipi- 
tated with polymerized actin was further confirmed by immu- 
nological experiments. To investigate the binding of actin to 
CK-II, i25I-labeled actin was pre-incubated for 12 h at room 
temperature with oligomeric CK-II  (a21~2), and then incubated 
for 2 h at 4°C with anti-serum against Drosophila CK-II~ in 
the presence of protein A-Sepharose. As expected, the anti- 
serum precipitated a radioactive immunocomplex only in the 
presence of both 125I-labeled actin and CK-II  (Fig. 2A). Simi- 
lar precipitation of actin and oligomeric CK-II  was also ob- 
served on incubation with specific IgG against Ascaris suum 
muscle actin in the presence of protein A-Sepharose (Fig. 2B). 
These two observations confirm that actin binds directly to 
CK-II. 
3.3. Characterization o f  actin as a CK-H inhibitor 
It is well known that CK-II  utilizes both ATP and GTP as 
phosphate donors [1], whereas only ATP binds to actin [22]. 
Therefore, the inhibitory effect of actin on CK-II  activity 
(phosphorylation of a-casein) was examined using ATP or 
GTP as a phosphate donor. As shown in Fig. 3A, actin in- 
hibits CK-II  activity when either ATP or GTP is used as a 
phosphate donor. Since actin as well as CK-II  bound to poly- 
Arg, the inhibitory effect of actin on CK-II activity was as- 
sessed in the presence or absence of poly-Arg. As expected, 
actin-induced inhibition of CK-II  activity was still observed 
when assayed in the absence of poly-Arg (Fig. 3B). In addi- 
tion, similar inhibition of CK-II  activity by actin was ob- 
served when other CK-II  phosphate acceptors, such as 94 
kDa glucose regulated protein (GRp94) or calreticulin 
(Ca2+-binding protein), were used instead of cx-casein under 
the same experimental conditions (data not shown). 
To determine the direct effect of actin on the ~-subunit 
(catalytic subunit) of CK-II, c~-monomeric CK-II (CK-II~) 
purified from plant cells [17] was used. As expected, the 
CK-IIc~-catalyzed phosphorylation of c~-casein was inhibited 
by actin in a dose-dependent manner (Fig. 4A). Under the 
given experimental conditions, phosphorylation of a-casein 
by CK-IIc~ increased linearly up to 20 min at 30°C (Fig. 
4B). This phosphorylation was inhibited completely when ac- 
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Fig. 3. (A) Inhibitory effect of actin on CK-II activity. Phosphoryla- 
tion of c~-casein by CK-II was carried out using 40 laM [y-32P]ATP 
(500 cprrdpmol; lanes 1-3) or 40 p-M [y-32p]GTP (500 cprrdpmol; 
lanes 4-6) as a phosphate donor under standard assay conditions. 
Lanes: 1,4, CK-II (0.1 lag) incubated for 20 min at 30°C with a- 
casein in the absence of poly-Arg (3 p-g) and actin (4 p.g); 2,5, in 
the presence of poly-Arg (3 p-g); 3,6, in the presence of poly-Arg (3 
p-g) and actin (4 lag). (B) Inhibitory effect of actin on CK-II activity 
in the presence or absence of poly-Arg. To examine the effect of 
poly-Arg, CK-II (0.1 p-g) was incubated for 20 min at 30°C with c~- 
casein (3 lag), actin (4 lag) and 40 laM [y-32P]ATP (500 cpm/pmol) in 
the absence (lanes 1-3) or presence (lanes 4-6) of poly-Arg (3 p.g). 
32p-labeled c~-casein i the reaction mixtures was detected by auto- 
radiography after SDS-PAGE. 
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Fig. 4. (A) Dose-effect of actin on phosphorylation f c~-casein by o~-monomeric CK-II (CK-IIa). CK-IIc~ activity was assayed under standard 
assay conditions in the presence of the indicated concentrations of actin, using 0c-casein as a phosphate acceptor. After incubation (20 min at 
30°C) in the absence of poly-Arg, 32p-labeled a-casein was detected by autoradiography after SDS-PAGE. Lanes: 1, phosphorylation f a-case- 
in by CK-IIc~ in the absence of actin; 2, lane 1+0.4 gg of actin; 3, lane 1+1.2 gg of actin; 4, lane 1+4 gg of actin; 5, lane 1+12 gg of actin. 
The autoradiogram was scanned by spectrophotometry and the inhibitory effect of actin represented as a percentage of that determined in the 
absence of actin (0). (B) Effect of actin on phosphorylation f a-casein by CK-II~. Phosphorylation f c~-casein by CK-II~ was examined at 
30°C under standard assay conditions. Purified actin (4 gg) was added to the reaction mixture at 5 min after the initiation of protein phosphor- 
ylation by addition of 40 gM [7-32p]ATP (500 cpm/pmol) (O). Phosphorylation f c~-casein by CK-II~ was also allowed to proceed in the ab- 
sence of actin (©). 
tin was added to the reaction mixtures at 5 min after incuba- 
tion of CK-I Ia with 40 JaM [7-32p]ATP (500 cpm/pmol) at 
30°C. These results suggest hat the actin-induced inhibition 
of CK-II activity is due to the binding of actin to the a-sub- 
unit of CK-II in vitro. 
3.4. Kinetics of CK-H inhibition by actin in vitro 
To characterize the kinetics of the actin-induced inhibition 
of CK-II activity, a-casein was used as a phosphate acceptor. 
As shown in Fig. 5, there was a substantial lteration in V,n= 
from 0.74 to 0.31 pmol min -1 when actin (approx. 0.46 p-M) 
was added to the reaction mixtures. However, no change of 
K,n (1.1 p.M) for the substrate was detected under the given 
experimental conditions. A similar inhibitory effect of actin 
against CK-II activity was observed when other CK-II sub- 
strates, such as GRp94 and myosin heavy chain, were used 
instead of a-casein as the phosphate acceptor for CK-II (data 
not shown). These results indicate that, with CK-II substrates, 
actin inhibits the activity of oligomeric CK-II (a2132) in a non- 
competitive manner. 
4. Discuss ion 
Muscle-type actin functions as a potent inhibitor for CK-II 
in vitro. This conclusion is supported by the following obser- 
vations: (i) actin inhibits CK-II activity in a dose-dependent 
manner, but does not affect two other kinases (A-kinase and 
MAP-kinase; Fig. 1); (ii) actin-induced inhibition is repro- 
duced when [y-32p]GTP is used instead of [y-32p]ATP as a 
phosphate donor for CK-II (Fig. 3A); (iii) actin inhibits 
CK-II activity through its direct binding to the a-subunit of 
CK-II in vitro (Fig. 4A); and (iv) both CK-II and actin can 
be coprecipitated with anti-serum against Drosophila CK-II[3 
or specific IgG against Ascaris suum muscle actin (Fig. 2). In 
addition, the actin-induced inhibition of CK-II activity was 
further characterized as being non-competitive with a-casein 
as a phosphate acceptor (Fig. 5). However, no significant 
effect of actin on CK-II activity was observed when actin 
was inactivated by treatment with 0.5 M NaC1 containing l 
mM EDTA and 0.5 mM EGTA. No inhibition of CK-II 
activity was detected when fragments generated from actin 
(after its limited digestion with modified trypsin) were incu- 
bated with CK-II and a-casein in vitro. 
Actins are abundant gene products, ubiquitously expressed 
in all eukaryotic ells [22], with highly conserved amino acid 
sequences among mammalian species and only 17 of the 375 
amino acid residues of human actin substituted with other 
amino acids in the actin sequence of Physarum polycephalum 
[21]. In vertebrates, there are at least six actin isoforms: four 
muscle types (skeletal muscle, cardiac, aorta-type smooth 
muscle and stomach-type smooth muscle actins) and two 
non-muscle types (cytoplasmic ~- and 7-actins) [23]. Muscle- 
type actins are tissue specific and functionally involved in 
muscle contractions, whereas cytoplasmic actins are expressed 
in many kinds of cell and participate in a variety of cell func- 
tions [24]. It seems that all types of actin may be responsible 
for various cell functions since more than 30 actin-binding 
proteins have been identified and characterized biochemically 
[22]. There is, probably, a common ability to inhibit the CK- 
II-catalyzed phosphorylation f intracellular CK-II substrates, 
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Fig. 5. Kinetics of actin-induced inhibition of CK-II activity. Dou- 
ble-reciprocal plots of inhibition by actin against CK-II activity 
were constructed. CK-II activity was assayed under standard condi- 
tions (10 rain at 30°C) using a-casein as a phosphate acceptor in 
the presence or absence of actin, s2p-labeled a-casein was detected 
with a liquid scintillation spectrometer. CK-II (approx. 0.1 gg) incu- 
bated with a-casein: (©--O) in the absence of actin (control); 
(~--e) in the presence of 0.23 pM actin; or (D--I) 0.46 gM. 
since muscle-type actins from rabbit muscle (Fig. 5), hen mus- 
cle and mouse brain inhibit CK-I I  activity in a dose-depend- 
ent manner without species specificity. 
Earlier reports concerning the regulatory mechanisms of 
CK-I I  activity in mammalian cells have demonstrated that 
(i) CK-II  activity is regulated through its phosphorylation 
by p34 cdc2 kinase [25], protein kinase C [26] or autophosphor- 
ylation of CK-II]3 [27]; (ii) nuclear calmodulin inhibits signif- 
icantly the phosphorylation of at least three major nuclear 
proteins (100, 42-44 and 37 kDa) by CK-II  in the nuclear 
fraction of rat liver in vitro [28]; and (iii) the interaction 
between DNA and CK- I I~ results in inhibition of CK-II  ac- 
tivity in vitro [29]. However, the suppressive mechanisms of 
CK-II  activity by these two cellular components (calmodulin 
and DNA) at the cellular level and their biological signifi- 
cances in the regulatory mechanisms involved in transcription 
and DNA replication remain to be elucidated. Our finding 
that actin acts as a potent inhibitor for CK-II  in vitro suggests 
that there is a further dimension of CK-II-mediated alteration 
of metabolic pathways and transcriptional regulation in dif- 
ferentiating or proliferating cells. This speculation is sup- 
ported by evidence that (i) CK-II  is characterized as one of 
the kinases responsible for metabolic alteration through phos- 
phorylation of a number of enzymes and cellular proteins 
during cell differentiation and proliferation [1,2]; and (ii) 
CK-II  plays an important role in positive and negative tran- 
scriptional regulations through specific phosphorylation of 
various transcriptional factors by the kinase [1,7 9], as men- 
tioned in Section 1. However, to understand clearly the bio- 
logical significance of actin in the regulation of CK-II- 
mediated signal transduction, the following fundamental ques- 
tions remain to be elucidated through further analytical stud- 
ies: (i) the biochemical mechanisms of actin involvement in 
CK-II-mediated signal transduction during cell proliferation 
and differentiation; and (ii) the physiological correlation be- 
tween CK-II, actin and other actin-associated protein kinases 
in mammalian cells. 
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